Literature DB >> 17851645

[Anticoagulation for stroke prevention. An update].

H C Koennecke1.   

Abstract

Given the projected rising prevalence of atrial fibrillation in the near future, an increasing number of older patients will have to be treated in order to prevent stroke and systemic embolism. This article summarizes recent developments in antithrombotic treatment and risk stratification for patients with atrial fibrillation and intends to abate the still prevailing reluctance towards anticoagulation in elderly patients.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17851645     DOI： 10.1007/s00115-007-2350-9

Source DB:  PubMed          Journal:  Nervenarzt        ISSN： 0028-2804            Impact factor:   1.214


  46 in total

Review 1.  Recent developments in atrial fibrillation.

Authors:  M Bilal Iqbal; Anil K Taneja; Gregory Y H Lip; Marcus Flather
Journal:  BMJ       Date:  2005-01-29

2.  The risk of recurrent stroke after intracerebral haemorrhage.

Authors:  H C Hanger; T J Wilkinson; N Fayez-Iskander; R Sainsbury
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01-12       Impact factor: 10.154

Review 3.  Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications.

Authors:  Hans-Christian Koennecke
Journal:  Neurology       Date:  2006-01-24       Impact factor: 9.910

4.  Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall.

Authors:  Brian F Gage; Elena Birman-Deych; Roger Kerzner; Martha J Radford; David S Nilasena; Michael W Rich
Journal:  Am J Med       Date:  2005-06       Impact factor: 4.965

5.  ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration With the North American Society of Pacing and Electrophysiology.

Authors:  V Fuster; L E Rydén; R W Asinger; D S Cannom; H J Crijns; R L Frye; J L Halperin; G N Kay; W W Klein; S Lévy; R L McNamara; E N Prystowsky; L S Wann; D G Wyse; R J Gibbons; E M Antman; J S Alpert; D P Faxon; V Fuster; G Gregoratos; L F Hiratzka; A K Jacobs; R O Russell; S C Smith; W W Klein; A Alonso-Garcia; C Blomström-Lundqvist; G De Backer; M Flather; J Hradec; A Oto; A Parkhomenko; S Silber; A Torbicki
Journal:  J Am Coll Cardiol       Date:  2001-10       Impact factor: 24.094

Review 6.  Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  Daniel E Singer; Gregory W Albers; James E Dalen; Alan S Go; Jonathan L Halperin; Warren J Manning
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

Review 7.  Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  Gregory W Albers; Pierre Amarenco; J Donald Easton; Ralph L Sacco; Philip Teal
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

8.  Risk factors for intracranial hemorrhage in outpatients taking warfarin.

Authors:  E M Hylek; D E Singer
Journal:  Ann Intern Med       Date:  1994-06-01       Impact factor: 25.391

9.  Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomised study.

Authors:  Ka Sing Wong; Christopher Chen; Ping Wing Ng; Tak Hong Tsoi; Ho Lun Li; Wing Chi Fong; Jonas Yeung; Chi Keung Wong; Kin Keung Yip; Hong Gao; Hwee Bee Wong
Journal:  Lancet Neurol       Date:  2007-05       Impact factor: 44.182

10.  Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study.

Authors:  C E Lovelock; A J Molyneux; P M Rothwell
Journal:  Lancet Neurol       Date:  2007-06       Impact factor: 44.182
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.